Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation

Abstract

Z, Oliyarnyk O, Kazdova L. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. Am J Physiol Gastrointest Liver Physiol 309: G100 -G111, 2015. First published June 4, 2015; doi:10.1152/ajpgi.00329.2014.-Nonalcoholic fatty liver disease is associated with chronic oxidative stress. In our study, we explored the antioxidant effect of antidiabetic metformin on chronic [high-fat diet (HFD)-induced] and acute oxidative stress induced by short-term warm partial ischemia-reperfusion (I/R) or on a combination of both in the liver. Wistar rats were fed a standard diet (SD) or HFD for 10 wk, half of them being administered metformin (150 mg·kg body wt Ϫ1 ·day Ϫ1 ). Metformin treatment prevented acute stress-induced necroinflammatory reaction, reduced alanine aminotransferase and aspartate aminotransferase serum activity, and diminished lipoperoxidation. The effect was more pronounced in the HFD than in the SD group. The metformin-treated groups exhibited less severe mitochondrial damage (markers: cytochrome c release, citrate synthase activity, mtDNA copy number, mitochondrial respiration) and apoptosis (caspase 9 and caspase 3 activation). Metformin-treated HFD-fed rats subjected to I/R exhibited increased antioxidant enzyme activity as well as attenuated mitochondrial respiratory capacity and ATP resynthesis. The exposure to I/R significantly increased NADH-and succinate-related reactive oxygen species (ROS) mitochondrial production in vitro. The effect of I/R was significantly alleviated by previous metformin treatment. Metformin downregulated the I/R-induced expression of proinflammatory (TNF-␣, TLR4, IL-1␤, Ccr2) and infiltrating monocyte (Ly6c) and macrophage (CD11b) markers. Our data indicate that metformin reduces mitochondrial performance but concomitantly protects the liver from I/R-induced injury. We propose that the beneficial effect of metformin action is based on a combination of three contributory mechanisms: increased antioxidant enzyme activity, lower mitochondrial ROS production, and reduction of postischemic inflammation. metformin; oxidative stress; mitochondrial respiration; liver injury; 31 P MR spectroscopy METFORMIN IS AN ORAL ANTIHYPERGLYCEMIC drug widely used in the treatment of Type 2 diabetes (T2D) (7). There is evidence that metformin also protects against oxidative stress in various tissues, although the antioxidant activity of metformin is not well understood. It has been shown that hyperglycemia is associated with increased reactive oxygen species (ROS) formation due to superoxide overproduction from the mitochondrial electron transport chain as a consequence of increased glycolysis (8). It has been hypothesized that the antioxidative effect of metformin is simply the consequence of its glucoselowering effect and subsequent decrease in superoxide anion production (3). Nevertheless, metformin has also displayed antioxidative characteristics in several models of oxidative stress without hyperglycemia (2,19,20,2...

Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs

“…However, during ischaemia the reduction in CS activity observed in hearts of untreated controls was prevented by metformin treatment. Both findings are similar to those previously reported in rat liver [30]. The mechanism for a baseline reduction in CS activity with metformin is uncertain, but may reflect a coordinated downregulation of electron transport chain complex I and tricarboxylic acid activities [31].…”

“…An effect of metformin to preserve CS activity during ischemia has been observed in rat hearts and liver and may be related to concurrent activation of AMPK. [30;32]. …”

Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress

“…Interestingly, metformin decreased H 2 O 2 generation by inhibiting both NOX activation and mitochondrial ROS production. The primary target of metformin in intact cells is the mitochondrion, where it inhibits respiratory chain complex I. Metformin was also reported to reduce mitochondrial damage expressed as an increased mitochondrial DNA copy number, cytochrome c release, caspase 3/9 activation, and mitochondrial ROS production 33–36 . In addition to an amelioration of oxidative stress, metformin also enhanced anti-oxidant activity and the expression of SOD2 in mesothelial cells, which was demonstrated for the first time in this study (Fig.…”

Metformin decreases testicular damages following ischaemia/reperfusion injury in rats

“…Combination of three contributory factors: increased antioxidant enzyme activity, lower mitochondrial ROS production and reduction of post-ischaemic inflammation have been suggested as mechanisms of metformin action to ameliorate I/R damage (Cahova et al, 2015). Combination of three contributory factors: increased antioxidant enzyme activity, lower mitochondrial ROS production and reduction of post-ischaemic inflammation have been suggested as mechanisms of metformin action to ameliorate I/R damage (Cahova et al, 2015).…”